Article
 

MahmudTaifoPharmacyModificationRifamycinPolyketide.pdf

Public Deposited

Downloadable Content

Download PDF
https://ir.library.oregonstate.edu/concern/articles/vd66w4836

Descriptions

Attribute NameValues
Creator
Abstract
  • Rifamycin B, a product of Amycolatopsis mediterranei S699, is the precursor of clinically used antibiotics that are effective against tuberculosis, leprosy and AIDS related mycobacterial infections. However, prolonged usage of these antibiotics has resulted in the emergence of rifamycin resistant strains of Mycobacterium tuberculosis. As part of our effort to generate better analogs of rifamycin, we substituted the acyltransferase (AT) domain of module 6 of rifamycin polyketide synthase (rifPKS) with that of module 2 of rapamycin PKS. The resulting mutants (rifAT6::rapAT2) of A. mediterranei S699 produced new rifamycin analogs, 24-desmethylrifamycin B and 24-desmethylrifamycin SV, which contained modification in the polyketide backbone. 24-desmethylrifamycin B was then converted to 24-desmethylrifamycin S, whose structure was confirmed by MS, NMR, and X-ray crystallography. Subsequently, 24-desmethylrifamycin S was converted to 24-desmethylrifampicin, which showed excellent antibacterial activity against several rifampicin-resistant M. tuberculosis strains.
  • Keywords: Multiple Drug Resistant, Domain Swapping, Polyketide Synthase, Rifamycin analogs, 24-desmethylrifamycin
  • Keywords: Multiple Drug Resistant, Domain Swapping, Polyketide Synthase, Rifamycin analogs, 24-desmethylrifamycin
  • Keywords: Multiple Drug Resistant, Domain Swapping, Polyketide Synthase, Rifamycin analogs, 24-desmethylrifamycin
  • Keywords: Multiple Drug Resistant, Domain Swapping, Polyketide Synthase, Rifamycin analogs, 24-desmethylrifamycin
Rights Statement

Relationships

Parents:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details MahmudTaifoPharmacyModificationRifamycinPolyketide.pdf 2017-10-27 Public Download